Skip to main content Skip to main navigation menu Skip to site footer
Published: 2021-11-05

Dysbiosis and obesity: implications of the gut microbiota

University of Pernambuco, Recife, Brazil
Federal University of Maranhão, General Surgery and Medical Clinic, São Luís, Maranhão, Brazil
Etianne Bartz Institute, Fortaleza, Ceará, Brazil
Porto Velho Hospital, Rondônia, Brazil
State University of Pará, Brazil
Medical Diagnostics Center, São Luís, Maranhão, Brazil
Human gut microbiota Obesity Dysbiosis Bowel changes


Introduction: Obesity has been considered a public health crisis, contributing as a risk factor for several important chronic diseases and even death. Considering this fact, it is noteworthy that there is a fundamental relationship between the intestine and health, and this organ is considered by modern medicine as our second brain in the concept of intestinal permeability. Within the evaluation of the food process, effective nutritional absorption can be altered due to imbalances, such as malabsorption, drug-nutrient interaction, changes in mucosal permeability, and, consequently, an imbalance in the gut microbiota. Dysbiosis is characterized by these negative changes that occur in the intestine. In this sense, the present systematic review study sought to answer: What influences can the microbiota composition have on the metabolic syndrome and obesity process? Objective: To elucidate the relationship between the presence of intestinal dysbiosis in the pathogenesis of obesity. Methods: This is a bibliographic review work where the MEDLINE, PubMed, and SciELO databases were consulted using the following descriptors: Human gut microbiota, obesity, dysbiosis. Results and Conclusion: Based on the literature that supports this theme, it was possible to observe that in the obese population there is an increase in bacteria of the genus Firmicutes and a decrease in the genus Bacteriodetes, with the blocking of factors and proteins that regulate the homeostasis of the absorption of lipids and fatty acids being observed thus being able to alter the energy metabolism leading to a greater accumulation of adipose tissue.


  1. Plaza-Díaz J, Solís-Urra P, Rodríguez-Rodríguez F, Olivares-Arancibia J, Navarro-Oliveros M, Abadía-Molina F, Álvarez-Mercado AI. The Gut Barrier, Gut microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. Int J Mol Sci. 2020 Nov 7;21(21):8351. doi: 10.3390/ijms21218351. PMID: 33171747; PMCID: PMC7664383.
  2. Wang L, Zhou J, Gober HJ, Leung WT, Huang Z, Pan X, Li C, Zhang N, Wang L. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype. Biomed Pharmacother. 2021 Jan;133:110958. doi: 10.1016/j.biopha.2020.110958. Epub 2020 Nov 7. PMID: 33171400.
  3. Fonseca FCP, Costa CL. Influência da nutrição sobre o sistema imune intestinal. Revista Ceres: Nutrição e Saúde, v.5, n.3, p.99-110, 2010.
  4. Leite L. et al. Papel da microbiota na manutenção da fisiologia gastrointestinal: uma revisão da literatura. Informative Geum Bulletin, v.5, n.2, p.54-61, 2014.
  5. Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017; v.16; p. 1823-1836.
  6. Underhil DM, Iliev I. D. The mycobiota: interactions between commensal fungi and the host immune system. Journal Nature Reviews Immunology, v. 14 p. 405– 416. 2014.
  7. Silva IRM. et al. Microbiota intestinal na obesidade e homeostase energética. Almanaque Multidisciplinar de Pesquisa. v.1, n.2, p. 28-50, 2016.
  8. Bernhard F. et al. Functional relevance of genes implicated by obesity genome-wide association study signals for human adipocyte biology. Diabetologia. v. 56, p. 311, 2013.
  9. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity. v. 32, p. 1431–1437, 2018.
  10. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. Vigitel Brasil 2016: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília, 2017.
  11. Tsukumo DM. et al . Translational research into gut microbiota: new horizons in obesity treatment. Arquivos Brasileiros de Endocrinologia & Metabologia. São Paulo, v. 57, n. 9, p. 753, 2013.
  12. Pantoja CL, Costa ACC, Costa PLS, Andrade MAH, Silva VV, Brito APSO, Garcia HCR. Diagnóstico e tratamento da disbiose: Revisão Sistemática. Revista Eletrônica Acervo Saúde, n. 32, p. e1368, 2019.
  13. Maffeyone PB, Dominguez IRL. Overfat Adults and Children in Developed Countries: The Public Health Importance of Identifying Excess Body Fat. Hypothesis and Theory. Frontiers in Public Health. 2017.
  14. Moraes ACF et al . Microbiota intestinal e risco cardiometabólico: mecanismos e modulação dietética. Arq Bras Endocrinol Metab, São Paulo, v. 58, n. 4, p. 317327, 2014.
  15. Carabotti M, Scirocco A, Maselli MA, Severi C. Annals Gastroenterologia. v. 28, n. 2, p. 203–209. 2015.
  16. Carvalho KMB, Dutra ES. Obesidade. In: CUPPARI, L. Nutrição Clinica no adulto. 3 ed. Barueri, SP: Manole, cap. 9, p. 185-213, 2014.
  17. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science. 1998. p. 1371–1374.
  18. Tilg H, Zmora N, Adolph TE, Elinav E. The gut microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020 Jan;20(1):40-54. doi: 10.1038/s41577-019-0198-4. Epub 2019 Aug 6. PMID: 31388093.
  19. Huttenhower C. et al. Struture, function and diversity of the healthy human microbiome. Nature, v. 486, n. 7402, p.207-214, 2012.
  20. Brandt KG, Sampaio MMSC, Miuki CJ. Importância da microbiota intestinal. Pediatria, v.28, n.2, p. 117-127, 2006.
  21. Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr. v. 139, p. 905-11, 2009.
  22. Belizário JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Frontiers in microbiology, v. 6, 2015.
  23. Oliveira AM, Hammes TO. Microbiota e barreira intestinal: implicações para obesidade.Clinical e Biomedical Research, v. 36, n. 4, 2016.

How to Cite

Pinto, A. C., Cavalcante, D. E. C., Araújo, E. A., Cabral, F. M., Santos, J. M., & Costa, K. V. (2021). Dysbiosis and obesity: implications of the gut microbiota. International Journal of Nutrology, 14(3).